CNS Pharmaceuticals, Inc. (CNSP) vs Traws Pharma, Inc. (TRAW)
A side-by-side comparison of CNS Pharmaceuticals, Inc. and Traws Pharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNSP
CNS Pharmaceuticals, Inc.
$5.30HealthcareDelayed quote: Oct 6, 2026, 3:32 PM EDT
TRAW
Traws Pharma, Inc.
$0.52HealthcareDelayed quote: Oct 6, 2026, 3:45 PM EDT
Total return — CNSP vs TRAW
growth of $100 · dividends reinvested · last 7yCNSP -100.0% (-85.6%/yr)TRAW -99.7% (-56.2%/yr)TRAW compounded faster over this window
Log scale — wide-divergence pair
CNSP TRAW
CNSP vs TRAW: by the numbers
- •TRAW is the larger company ($8M vs $8M market cap).
- •TRAW is profitable (328.67% net margin) while CNSP runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | CNSP | TRAW |
|---|---|---|
| P/B ratio | 0.43 | N/A |
Profitability
| Metric | CNSP | TRAW |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -640.68% |
| Net margin | 0.00% | 328.67% |
| ROE | -91.75% | N/A |
| ROIC | -92.94% | N/A |
Growth (annualized)
| Metric | CNSP | TRAW |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 64.60% |
| Total return CAGR (5Y) | -91.63% | -64.14% |
Frequently asked
- Is CNSP or TRAW more profitable?
- TRAW runs the higher net margin — CNSP at 0.00% versus TRAW at 328.67%.
- How have CNSP and TRAW total returns compared?
- Over the past 5 years, CNSP delivered -91.63% and TRAW delivered -64.14% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
CNS Pharmaceuticals ROETraws Pharma ROECNS Pharmaceuticals operating marginTraws Pharma operating marginCNS Pharmaceuticals revenue growthTraws Pharma revenue growthCNS Pharmaceuticals free cash flowTraws Pharma free cash flow
CNS Pharmaceuticals & Traws Pharma appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.